tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cryoport price target lowered to $10 from $13 at BTIG

BTIG lowered the firm’s price target on Cryoport (CYRX) to $10 from $13 and keeps a Buy rating on the shares following the firm’s survey of biopharma manufacturers. R&D Services budgets will likely face the most risk and headwinds over the next 2 years, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1